Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization
Hospira Inc. recalls specific lots of Ketorolac Tromethamine Injection due to crystallization. Check lot numbers and expiration dates immediately.
Stop using this now
Crystallization
Contact the company
What happened, in plain English
Hospira Inc. is recalling KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials because the drug has crystallized. This recall affects vials distributed nationwide in the U.S. as well as internationally to Guam and Singapore. The record does not specify a remedy or return process. Read more at govinfonow.com/recall/45018-hospira-inc-recalls-ketorolac-tromethamine-inj-usp-60-mg-30.
Source Summary by GovInfoNow · govinfonow.com/recall/45018-hospira-inc-recalls-ketorolac-tromethamine-inj-usp-60-mg-30 · Updated October 12, 2026 · FDA enforcement record: FDA #D-0483-2015
Cite this page
“Hospira Recalls Ketorolac Tromethamine Injections Due to Crystallization.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45018-hospira-inc-recalls-ketorolac-tromethamine-inj-usp-60-mg-30. Based on FDA recall #D-0483-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0483-2015%22&limit=1).
Why it’s dangerous
The hazard is crystallization within the single-dose vials. Crystallized medication can pose serious risks if injected, such as blockage of blood vessels or unpredictable drug delivery, although the specific injury mechanism is not detailed in this record.
Who’s affected
Patients and healthcare providers who have received or administered KETOROLAC Tromethamine Injection from the specific lots listed in the record. Individuals using these vials for intravenous (I.V.) or intramuscular (I.M.) use are at risk.
How to tell if you have this one
Look for KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials manufactured by Hospira, Inc. or labeled under NOVAPLUS. Check the NDC numbers (0409-3796-01 or 0409-3796-49) and specific lot numbers such as 26-098-DK, 29-239-DK, 34-540-DK, 37-037-DK, 41-282-DK, 44-076-DK, 45-240-DK, 46-306-DK, and 26-097-DK against their expiration dates.
- Brand
Hospira- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
U.S. Nationwide and International: Guam and Singapore.
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-0482-2015 | KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill, Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3795-01 --- Also labeled under NOVAPLUS label NDC 0409-3795-49; NDC 0409-3795-01, Lot number: 25-047-DK, 25-048-DK, Exp 1JAN2015; Lot number 26-151-DK, Exp. Date:1FEB2015; Lot number: 28-059-DK, 28-071-DK, 28-072-DK, 28-479-DK, 28-480-DK, Exp. Date:1APR2015; Lot number: 29-556-DK, 29-557-DK, Exp. Date:1MAY2015; Lot number: 35-232-DK, 35-233-DK, 35-234-DK, 35-501-DK, Exp. Date:1NOV2015; Lot number: 36-341-DK, 36-342-DK, 36-343-DK, 36-353-DK, 36-429-DK, 36-430-DK, Exp. Date:1DEC2015; Lot number: 37-141-DK, 37-142-DK, 37-144-DK, 37-145-DK, 37-353-DK, Exp. Date:1JAN2016; Lot number: 38-141-DK, 38-143-DK, Exp. Date:1FEB2016; Lot number: 39-014-DK, 39-104-DK, Exp. Date:1MAR2016; Lot number: 40-301-DK, 40-536-DK, 40-537-DK, 40-544-DK, 40-548-DK, Exp. Date:1APR2016; Lot number: 41-078-DK, Exp. Date:1MAY2016; Lot number: 42-207-DK, 42-253-DK, Exp. Date:1JUN2016; Lot number: 45-358-DK, 45-359-DK, Exp. Date:1SEP2016; Lot number: 46-043-DK, 46-044-DK, 46-047-DK, Exp. Date:1OCT2016 AND NOVAPLUS LABEL NDC 0409-3795-49, Lot number: 27-101-DK, Exp. Date:1MAR2015; Lot number: 35-229-DK, Exp. Date:1NOV2015; Lot number: 36-217-DK, 36-218-DK, Exp. Date:1DEC2015 and Lot number: 40-534-DK, Exp. Date:1APR2016 | HOSPIRA = 13,720,475 vials, NOVAPLUS = 1,528,500 vials | 0409-3793-19, 0409-3793-01, 0409-3793-25, 0409-3795-19, 0409-3795-01, 0409-3795-25, 0409-3796-19, 0409-3796-01, 0409-3796-25, 0409-3795-49 |
| D-0483-2015 | KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49; NDC 0409-3796-01, Lot number: 26-098-DK, Exp. Date:1FEB2015; Lot number: 29-239-DK, 29-240-DK, Exp. Date:1MAY2015; Lot number: 34-540-DK, Exp. Date:1OCT2015; Lot number: 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, Exp. Date:1JAN2016; Lot number: 41-282-DK, 41-284-DK, Exp. Date:1MAY2016; Lot number: 44-076-DK, Exp. Date:1AUG2016; Lot number: 45-240-DK, Exp. Date:1SEP2016 and Lot number: 46-306-DK, Exp. Date:1OCT2016 AND NOVAPLUS label NDC 0409-3796-49, Lot number: 26-097-DK, Exp. Date:1FEB2015. | HOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vials | 0409-3793-19, 0409-3793-01, 0409-3793-25, 0409-3795-19, 0409-3795-01, 0409-3795-25, 0409-3796-19, 0409-3796-01, 0409-3796-25, 0409-3796-49 |
What to do — step by step
Verify Lot Numbers
Check the NDC numbers (0409-3796-01 or 0409-3796-49) and lot numbers on your vials against the recalled list.
Stop Using Affected Vials
Do not use any vials that match the recalled lot numbers due to the risk of crystallization.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “U.S. Nationwide and International: Guam and Singapore.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Which lot numbers are affected?
Affected lots include 26-098-DK, 29-239-DK, 29-240-DK, 34-540-DK, 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, 41-282-DK, 41-284-DK, 44-076-DK, 45-240-DK, 46-306-DK, and 26-097-DK.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0483-2015 (January 23, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0483-2015 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.